ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,195Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 2888

$1.62M Total Retail Price of All Prescriptions

Rank: 56 out of 2888

1,461 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,461 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

20% of this provider’s 1,461 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 25,268 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,417 1,139 1 2
LEVOTHYROXINE SODIUM 1,357 1,161 2 1
LISINOPRIL 1,263 1,063 3 3
HYDROCODONE-ACETAMINOPHEN 1,144 764 S3 4 4
OMEPRAZOLE 1,081 808 5 7
AMLODIPINE BESYLATE 1,002 802 6 5
FUROSEMIDE 997 817 7 6
METOPROLOL TARTRATE 874 753 8 10
METFORMIN HCL 859 655 9 8
HYDROCHLOROTHIAZIDE 851 663 10 15
ATORVASTATIN CALCIUM 588 460 11 9
WARFARIN SODIUM 502 463 12 22
GABAPENTIN 474 352 13 13
TRAMADOL HCL 398 332 14 16
LIPITOR 367 320 15 78
DONEPEZIL HCL 357 342 16 26
CARVEDILOL 354 281 17 21
PRAVASTATIN SODIUM 352 301 18 12
CLOPIDOGREL 349 261 19 30
METOPROLOL SUCCINATE 322 274 20 11
CRESTOR 302 223 21 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 294 250 22 28
SERTRALINE HCL 291 182 23 27
CLONIDINE HCL 287 190 24 39
RISPERIDONE 287 216 24 72
POTASSIUM CHLORIDE 283 191 26 14
ZOLPIDEM TARTRATE 279 186 27 17
ATENOLOL 265 208 28 25
ALENDRONATE SODIUM 259 219 29 23
LANTUS 243 185 30 45
CITALOPRAM HBR 241 173 31 24
NEXIUM 241 183 31 19
NAMENDA 239 221 33 34
PLAVIX 217 179 34 40
LOVASTATIN 212 205 35 41
SULFAMETHOXAZOLE-TRIMETHOPRIM 206 170 36 88
ALLOPURINOL 191 149 37 37
NOVOLOG 190 172 38 114
GLIPIZIDE 187 146 39 50
LEVOFLOXACIN 186 170 40 57
DIGOXIN 181 160 41 55
QUETIAPINE FUMARATE 179 110 42 66
TERAZOSIN HCL 175 136 43 152
LEVETIRACETAM 159 87 44 103
TRAZODONE HCL 158 93 45 43
PANTOPRAZOLE SODIUM 157 141 46 33
MELOXICAM 156 92 47 31
MIRTAZAPINE 147 126 48 54
SPIRONOLACTONE 146 120 49 70
AMITRIPTYLINE HCL 144 112 R 50 74
ISOSORBIDE MONONITRATE ER 144 143 50 51
AZITHROMYCIN 142 97 52 38
DIOVAN 141 103 53 35
VERAPAMIL ER 138 116 54 104
FAMOTIDINE 136 121 55 75
POLYETHYLENE GLYCOL 3350 132 107 56 93
HYDRALAZINE HCL 129 114 57 59
DIOVAN HCT 125 99 58 61
BUSPIRONE HCL 124 78 59 148
ESCITALOPRAM OXALATE 124 74 59 62
KLOR-CON M10 124 118 59 118
LYRICA 124 96 59 69
PREDNISONE 123 109 63 42
LIDODERM 118 110 64 105
KLOR-CON M20 116 96 65 90
TRIAMTERENE-HCTZ 113 71 66 63
ENALAPRIL MALEATE 111 90 67 49
GLIMEPIRIDE 108 94 68 36
JANUVIA 105 90 69 48
NOVOLIN R 105 75 69 109
DIVALPROEX SODIUM 103 47 71 100
TAMSULOSIN HCL 103 90 71 29
ALBUTEROL SULFATE 102 93 73 134
LOSARTAN POTASSIUM 96 91 74 18
GLYBURIDE 94 80 R 75 58
OXYBUTYNIN CHLORIDE ER 93 51 76 132
FLUTICASONE PROPIONATE 93 79 76 32
RANITIDINE HCL 88 77 78 56
NIFEDIPINE ER 84 84 79 76
CYMBALTA 84 38 79 44
AMLODIPINE BESYLATE-BENAZEPRIL 81 69 81 67
ESTRADIOL 80 47 R 82 139
PROPRANOLOL HCL 79 46 83 164
FLUOXETINE HCL 79 64 83 83
PHENYTOIN SODIUM EXTENDED 78 0 85 128
ACTOS 75 68 86 108
PAROXETINE HCL 75 65 86 84
RAMIPRIL 74 55 88 73
NITROFURANTOIN MONO-MACRO 74 63 88 162
VALPROIC ACID 72 15 90 278
VENLAFAXINE HCL 72 62 90 246
PHENYTOIN 71 37 92 302
PROAIR HFA 71 64 92 71
CARBIDOPA-LEVODOPA 71 71 92 113
CYCLOBENZAPRINE HCL 70 28 R 95 68
LEVOTHROID 70 60 95 333
TRAMADOL HCL-ACETAMINOPHEN 68 65 97 95
NAPROXEN 67 48 98 80
LEVEMIR 66 63 99 135
CAPTOPRIL 65 55 100 225
ADVAIR DISKUS 64 55 101 60
DILTIAZEM ER 63 63 102 182
QUINAPRIL HCL 63 56 102 179
BENZTROPINE MESYLATE 63 34 R 102 191
NYSTATIN 63 53 102 178
BACLOFEN 62 43 106 121
TRICOR 62 45 106 91
DETROL LA 61 44 108 192
DILTIAZEM 24HR ER 61 48 108 264
FENTANYL 61 54 S2 108 126
IPRATROPIUM BROMIDE 60 52 111 188
SPIRIVA 60 46 111 79
CILOSTAZOL 60 54 111 165
FINASTERIDE 60 47 111 102
PROMETHAZINE HCL 59 29 R 115 96
METOCLOPRAMIDE HCL 57 43 116 116
SEROQUEL 56 31 117 143
IBUPROFEN 55 32 118 87
FENOFIBRATE 54 52 119 65
EXELON 54 47 119 106
BENAZEPRIL HCL 53 50 121 77
VERAPAMIL HCL 50 47 122 368
ZETIA 50 46 122 81
GLIPIZIDE ER 50 49 122 107
METFORMIN HCL ER 50 36 122 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.